MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Quanterix Corp

Închisă

SectorSănătate

3.23 -8.24

Rezumat

Modificarea prețului

24h

Curent

Minim

3.23

Maxim

3.52

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+57.14% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-137M

159M

Deschiderea anterioară

11.47

Închiderea anterioară

3.23

Sentimentul știrilor

By Acuity

50%

50%

159 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 apr. 2026, 23:49 UTC

Evenimente importante

New Zealand 1Q Inflation Higher Than Expected

20 apr. 2026, 23:10 UTC

Acțiuni populare

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 apr. 2026, 22:53 UTC

Principalele dinamici ale pieței

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 apr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 apr. 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 apr. 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 apr. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 apr. 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 apr. 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 apr. 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 apr. 2026, 22:31 UTC

Achiziții, Fuziuni, Preluări

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 apr. 2026, 22:26 UTC

Achiziții, Fuziuni, Preluări

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 apr. 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 apr. 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

West African Resources Aims for Acquisition to Be Completed by End-2026

20 apr. 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 apr. 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

West African Resources Says Acquisition Would Be for A$175 Million

20 apr. 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 apr. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 apr. 2026, 22:01 UTC

Achiziții, Fuziuni, Preluări

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 apr. 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 apr. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 apr. 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 apr. 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 apr. 2026, 21:13 UTC

Câștiguri

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 apr. 2026, 21:10 UTC

Câștiguri

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 apr. 2026, 21:09 UTC

Câștiguri

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 apr. 2026, 21:08 UTC

Câștiguri

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 apr. 2026, 21:07 UTC

Câștiguri

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 apr. 2026, 21:05 UTC

Câștiguri

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 apr. 2026, 21:05 UTC

Câștiguri

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

57.14% sus

Prognoză pe 12 luni

Medie 5.5 USD  57.14%

Maxim 7 USD

Minim 4 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

159 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat